| abstract |
The present invention provides a pharmaceutical composition that is for treating or preventing unpleasant symptoms associated with an increase in progestogens and that contains, as an active ingredient, a selective mineralocorticoid receptor antagonist or a derivative thereof, or a pharmaceutically acceptable salt thereof. The present invention also provides a method that is for treating or preventing unpleasant symptoms associated with an increase in progestogens and that comprises administrating a pharmaceutical composition containing, as an active ingredient, a selective mineralocorticoid receptor antagonist or a derivative thereof, or a pharmaceutically acceptable salt thereof. The present invention is useful for treating or preventing unpleasant symptoms associated with an increase in progestogens, and is highly effective and has few side effects. |